Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma

被引:11
|
作者
Yamasaki, T [1 ]
Kurokawa, F [1 ]
Shirahashi, H [1 ]
Kusano, N [1 ]
Hironaka, K [1 ]
Okita, K [1 ]
机构
[1] Yamaguchi Univ, Dept Internal Med 1, Ube, Yamaguchi 7558505, Japan
关键词
radiofrequency ablation; hepatocellular carcinoma; combined angiography and computed tomography; balloon occlusion; percutaneous local treatment;
D O I
10.1002/1097-0142(20010401)91:7<1342::AID-CNCR1137>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Radiofrequency ablation (RFA) for patients with hepatocellular carcinoma (HCC) has been reported previously. This technique is superior to percutaneous microwave coagulation therapy (PMCT) for the enlargement of the necrotic area. Therefore, a few treatment sessions of RFA for patients with small HCC lesions measuring < 3 cm in greatest dimension can achieve complete necrosis. To achieve this with a one-treatment RFA session, the authors designed the technique of RFA with angiography combined with computed tomography (angio-CT) assistance. The advantages of this technique are that it is possible to detect small satellite nodules and to evaluate the real-time therapeutic effect immediately after RFA. METHODS. Ten patients with 12 HCC lesions measuring < 4 cm in greatest dimension underwent RFA with angio-CT assistance. The authors performed standard RFA for six patients (seven tumors) and RFA with balloon occlusion of the hepatic artery (balloon-occluded RFA [BoRFA]) for four patients (five tumors). Final therapeutic efficacy was evaluated with dynamic CT scans performed 2 weeks after treatment. RESULTS. On CT arteriography (CTA) obtained immediately after treatment, a hyperattenuating ring around the nonenhanced region was apparent in all patients. On CT scans obtained 2 weeks after treatment, this ring disappeared, and the greatest dimension of the nonenhanced region was slightly larger than that on the CTA obtained immediately after treatment. The authors achieved complete eradication with one treatment session of RFA in 8 of 10 patients (80%). Local recurrence occurred in one patient 10 months after treatment. The greatest dimension of the area coagulated by BoRFA was significantly larger (greatest long-axis dimension, 38.2 +/- 2.8 mm; greatest short-axis dimension, 35.0 +/- 1.7 mm; n = 5 lesions) than without it (greatest long-axis dimension, 30.0 +/- 4.1 mm; greatest short-axis dimension, 27.0 +/- 4.3 mm; n = 4 lesions; greatest long-axis dimension, P = 0.009; greatest short-axis dimension, P = 0.006). No major complications occurred in any patient. CONCLUSIONS. The authors were able to achieve success with a single treatment session in patients with small HCC using RFA with angio-CT assistance. They consider that RFA with angio-CT assistance is a safe and effective technique for the treatment of patients with small HCC. (C) 2001 American Cancer Society.
引用
收藏
页码:1342 / 1348
页数:7
相关论文
共 50 条
  • [1] ADOPTION OF COMPUTED TOMOGRAPHY IMAGE GUIDANCE AMONG HEPATOCELLULAR CARCINOMA PATIENTS WITH PERCUTANEOUS RADIOFREQUENCY ABLATION
    Huo, J.
    Chung, T. H.
    Aloia, T. A.
    Sheu, T.
    Shih, Y. T.
    VALUE IN HEALTH, 2016, 19 (03) : A136 - A136
  • [2] Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome
    Kan, Xuefeng
    Wang, Yong
    Han, Ping
    Yao, Qi
    Qian, Kun
    Xiong, Bin
    Zheng, Chuansheng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7751 - 7757
  • [3] Percutaneous Radiofrequency Ablation Therapy for Recurrent Hepatocellular Carcinoma
    Nishikawa, Hiroki
    Osaki, Yukio
    Iguchi, Eriko
    Takeda, Haruhiko
    Ohara, Yoshiaki
    Sakamoto, Azusa
    Hatamaru, Keiichi
    Saito, Sumio
    Nasu, Akihiro
    Kita, Ryuichi
    Kimura, Toru
    ANTICANCER RESEARCH, 2012, 32 (11) : 5059 - 5065
  • [4] Utility of percutaneous radiofrequency thermal ablation therapy combined with transarterial chemoembolization for hepatocellular carcinoma
    Ono, Kaori
    Tamai, Tsutomu
    Toyokura, Eriko
    Hori, Takeshi
    Sakurai, Kazuhiro
    Tabu, Kazuaki
    Oshige, Akihiko
    Oda, Kohei
    Imanaka, Dai
    Kumagai, Kotaro
    Mawatari, Seiichi
    Moriuchi, Akihiro
    Uto, Hirofumi
    Oketani, Makoto
    Ido, Akio
    Tsubouchi, Hirohito
    HEPATOLOGY, 2013, 58 : 1254A - 1254A
  • [5] Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow - Comparison with standard percutaneous radiofrequency ablation therapy
    Yamasaki, T
    Kurokawa, F
    Shirahashi, H
    Kusano, N
    Hironaka, K
    Okita, K
    CANCER, 2002, 95 (11) : 2353 - 2360
  • [6] Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow - Comparison with standard percutaneous radiofrequency ablation therapy
    Rhim, H
    CANCER, 2003, 98 (02) : 433 - 434
  • [7] Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma
    Gandhi, S.
    Iannitti, D. A.
    Mayo-Smith, W. W.
    Dupuy, D. E.
    CLINICAL RADIOLOGY, 2006, 61 (10) : 888 - 891
  • [8] The clinical efficiency of TACE combined with simultaneous computed tomography‐guided radiofrequency ablation for advanced hepatocellular carcinoma
    Peng Yuan
    Fei Wang
    Guangyu Zhu
    Baoan Chen
    Investigational New Drugs, 2021, 39 : 1383 - 1388
  • [9] Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma
    Kurokohchi, Kazutaka
    Watanabe, Seishiro
    Masaki, Tsutomu
    Hosomi, Naoki
    Miyauchi, Yoshiaki
    Himoto, Takashi
    Kimura, Yasuhiko
    Nakai, Seiji
    Deguchi, Akihiro
    Yoneyama, Hirohito
    Yoshida, Shuhei
    Kuriyama, Shigeki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (10) : 1426 - 1432
  • [10] Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma
    Kazutaka Kurokohchi
    Seishiro Watanabe
    Tsutomu Masaki
    Naoki Hosomi
    Yoshiaki Miyauchi
    Takashi Himoto
    Yasuhiko Kimura
    Seiji Nakai
    Akihiro Deguchi
    Hirohito Yoneyama
    Shuhei Yoshida
    Shigeki Kuriyama
    World Journal of Gastroenterology, 2005, (10) : 1426 - 1432